Application 219123
- Type
- ANDA
- Sponsor
- BIONPHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TRANEXAMIC ACID | TRANEXAMIC ACID | TABLET;ORAL | 650MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219123-001 | TRANEXAMIC ACID | TRANEXAMIC ACID | 650MG | TABLET / ORAL | 2025-08-19 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219123-001 | TRANEXAMIC ACID | 650MG | TABLET / ORAL | 2025-08-19 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A219123-001 | TRANEXAMIC ACID | 650MG | TABLET / ORAL | 2025-08-19 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A219123-001 | TRANEXAMIC ACID | 650MG | TABLET / ORAL | AB | 2025-08-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219123-001 | TRANEXAMIC ACID | 650MG | TABLET / ORAL | AB | 2025-08-19 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219123-001 | TRANEXAMIC ACID | 650MG | TABLET / ORAL | 2025-08-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A219123-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219123-001 | AB | 1 | 31067a03dcf5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tranexamic Acid | TRANEXAMIC ACID | ANI Pharmaceuticals, Inc. | 82bc4879-bcf5-47c4-8636-a73c4e7d0de9 | 2025-09-19 | Warnings, Adverse reactions | Tranexamic Acid TRANEXAMIC ACID |
| Tranexamic Acid | TRANEXAMIC ACID | Mylan Institutional LLC | 6f033f1e-8c78-4c87-b870-6493944315ff | 2025-09-08 | Boxed warning, Warnings, Adverse reactions | Tranexamic Acid TRANEXAMIC ACID |
| Cyklokapron | TRANEXAMIC ACID | Pfizer Laboratories Div Pfizer Inc | 6e89a7d9-4da4-42aa-b7f8-c602c24eefe5 | 2025-09-03 | Boxed warning, Warnings, Adverse reactions | TRANEXAMIC ACID |
| tranexamic acid | TRANEXAMIC ACID | Provepharm Inc. | 1b8c3500-8e87-4b6e-b6a9-8da5f9c00820 | 2025-08-12 | Warnings, Adverse reactions | tranexamic acid TRANEXAMIC ACID |
| TRANEXAMIC ACID | TRANEXAMIC ACID | Dr. Reddy's Laboratories Inc. | e5a52dad-e328-48f2-9182-4df46f5572ef | 2025-08-01 | Warnings, Adverse reactions | TRANEXAMIC ACID TRANEXAMIC ACID |
| Tranexamic Acid | TRANEXAMIC ACID | Actavis Pharma, Inc. | 3f07e93b-3568-487e-894f-8f90e5a0960a | 2025-07-15 | Warnings, Adverse reactions | Tranexamic Acid TRANEXAMIC ACID |
| TRANEXAMIC ACID IN SODIUM CHLORIDE | TRANEXAMIC ACID | Amneal Pharmaceuticals Private Limited | 615a9bec-f769-4774-8b05-22473b93668c | 2025-05-30 | Warnings, Adverse reactions | TRANEXAMIC ACID |
| tranexamic acid in sodium chloride | TRANEXAMIC ACID | Avenacy Inc. | c3aad84a-aa99-42a0-b4b6-6fdee7585e19 | 2025-03-28 | Warnings, Adverse reactions | TRANEXAMIC ACID |
| TRANEXAMIC ACID | TRANEXAMIC ACID | Proficient Rx LP | 416cdb61-31fb-4554-835f-a7744aa33b61 | 2025-03-01 | Warnings, Adverse reactions | TRANEXAMIC ACID TRANEXAMIC ACID |
| Tranexamic Acid | TRANEXAMIC ACID | Nexus Pharmaceuticals LLC | c479dccd-15c6-47c2-9675-680ebb9db2cb | 2025-02-26 | Warnings, Adverse reactions | Tranexamic Acid TRANEXAMIC ACID |
| Tranexamic Acid in Sodium Chloride | TRANEXAMIC ACID | HP Halden Pharma AS | 0c638812-ba60-49fe-a715-f40246b6cbf7 | 2025-01-14 | Warnings, Adverse reactions | TRANEXAMIC ACID |
| Tranexamic Acid | TRANEXAMIC ACID | Caplin Steriles Limited | 6326bdbf-fb2e-451a-a0a0-7d0b59ce5438 | 2025-01-03 | Warnings, Adverse reactions | Tranexamic Acid TRANEXAMIC ACID |
| TRANEXAMIC ACID IN SODIUM CHLORIDE | TRANEXAMIC ACID | Fresenius Kabi USA, LLC | 63f6c65f-b06b-4905-8ff8-3ac87569c7e0 | 2024-11-15 | Warnings, Adverse reactions | TRANEXAMIC ACID |
| Tranexamic Acid | TRANEXAMIC ACID | Emcure Pharmaceuticals Limited | ceea739a-21dd-4c3a-9ef6-2b7ab2bdd95a | 2024-10-28 | Tranexamic Acid TRANEXAMIC ACID | |
| Tranexamic Acid | TRANEXAMIC ACID | Sagent Pharmaceuticals | 80465b90-3f92-4e35-b2ba-69871bbd4a7f | 2024-08-14 | Warnings, Adverse reactions | Tranexamic Acid TRANEXAMIC ACID |
| Tranexamic Acid | TRANEXAMIC ACID | Bryant Ranch Prepack | af95be04-a6ea-4789-8e79-7dcad332c640 | 2024-08-08 | Warnings, Adverse reactions | Tranexamic Acid TRANEXAMIC ACID |
| TRANEXAMIC ACID IN SODIUM CHLORIDE | TRANEXAMIC ACID | Gland Pharma Limited | f06f07de-bedf-4b37-b15e-0959e0a154e6 | 2024-04-19 | Warnings, Adverse reactions | TRANEXAMIC ACID |
| tranexamic acid | TRANEXAMIC ACID | Avenacy, Inc. | 00630e54-0e84-465d-96a5-63486c87dcd9 | 2024-03-15 | Warnings, Adverse reactions | tranexamic acid TRANEXAMIC ACID |
| Tranexamic Acid | TRANEXAMIC ACID | Armas Pharmaceuticals Inc. | a3468b9f-a1c1-43ca-afc0-5b32c8f58b83 | 2024-02-06 | Warnings, Adverse reactions | Tranexamic Acid TRANEXAMIC ACID |
| TRANEXAMIC ACID | TRANEXAMIC ACID | HF Acquisition Co LLC, DBA HealthFirst | c53e2b38-6c49-acae-e053-2995a90ae9df | 2024-01-30 | Warnings, Adverse reactions | TRANEXAMIC ACID TRANEXAMIC ACID |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.